Adjuvant Capital is a life sciences investment firm focused on global health. We make $10-$25 million investments in ambitious companies targeting opportunities in high burden and neglected disease. 

Themis Bioscience

Evofem Biosciences

AN2 Therapeutics

YS Biopharma

Adjuvant Capital

Adjuvant Capital is a venture capital firm that specializes in investing in transformative healthcare technologies. The company aims to support and accelerate the development of medical solutions that can address significant unmet needs in healthcare.

COM:ADJUVANTCAPITAL

Adjuvant Capital

Filings Not Available